Clinical presentations and therapy of polysubstance dependence in patients with schizophrenia
Authors:
- 1 January 2021
- journal article
- research article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 121 (4) , 63-69
Abstract
The article presents the results of a clinical therapeutic and follow-up study of patients with a 'dual diagnosis' (polysubstance dependence comorbid with schizophrenia: paranoid schizophrenia or schizotypal disorder). To study clinical/dynamic changes of polysubstance dependence in patients with schizophrenia (paranoid schizophrenia, schizotypal disorder) and to evaluate the duration and quality of therapeutic remissions. Two hundred and sixty-six male patients, including 176 patients with dependence syndrome and 90 patients with both dependence syndrome and schizophrenia, were studied. Patients with the 'dual diagnosis' are characterized by early social maladjustment, earlier social deformation, lack of social skills and preference for a lonely lifestyle. The clinical and dynamic characteristics of dependence syndrome in patients with 'dual diagnosis' include older age of the first use of a psychoactive substance (PS), preference of alcohol as the first PS, experiment as the most frequent motivation for using PS (due to thought disorder), and the treatment of psychopathological disorders (PS like medicine) with a chaotic pattern being the most common in the use, a tendency to hospitalism. The success of the treatment of patients with 'dual diagnosis' is possible by combining the therapy of endogenous disease and polysubstance dependence.Keywords
This publication has 19 references indexed in Scilit:
- Epidemiology, etiology and treatment of patients with psychosis and co-morbid substance use disorderTherapeutische Umschau, 2018
- Addiction and schizophrenia: A translational perspectiveSchizophrenia Research, 2018
- Clinical Epidemiology of Single Versus Multiple Substance Use DisordersMedical Care, 2017
- Evidence for differential opioid use disorder in schizophrenia in an addiction treatment populationSchizophrenia Research, 2017
- Epidemiology and Risk Factors Influencing Schizophrenia2016
- Comorbid substance use disorders in schizophrenia: A latent class approachPsychiatry Research, 2015
- Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?BMC Psychiatry, 2012
- Mental disorders as risk factors for substance use, abuse and dependence: results from the 10‐year follow‐up of the National Comorbidity SurveyAddiction, 2010
- Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuseSchizophrenia Research, 2004
- First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidolSchizophrenia Research, 2004